Meet the founder: Modern Synthesis’ Jen Keane on biomaterials, bacteria, and designer bags…
How efficient are bugs at creating bags, and how scalable is Modern Synthesis’ patent-pending biomaterials technology?
How efficient are bugs at creating bags, and how scalable is Modern Synthesis’ patent-pending biomaterials technology?
Ayana Bio has signed a deal with Wooree Green Science to develop saffron and other bioactives made via plant cell culture.
At a time when many alt protein companies are struggling to raise funds, Infinite Roots (formerly Mushlabs) has netted $58m from investors including German food retail giant (REWE) and the holding company behind Haribo (HRH).
The capital injection will also help advance work to develop Cavendish bananas engineered to resist the devastating fungal disease Fusarium wilt.
Industrial-scale insect farming is not for the faint-hearted. So what business models make sense, and who is going to fund the next wave of facilities?
Are GLP-1 drugs an ‘existential threat’ to the food industry or an opportunity for some creative thinking?
We’re kidding ourselves if we think we can make the unit economics add up for cultivated meat without deploying ‘much much larger’ bioreactors, says Ark Biotech.
Can money really grow on trees? Undoubtedly, says Ethan Steinberg at agroforestry startup Propagate. But it doesn’t happen overnight, so farmers looking to plant trees among their crops need support, and upfront capital.
Edete—which offers precision pollination as a service (PPaS)—helps Mother Nature by applying pollen directly to trees in a highly targeted manner.
MFL combines solid state fermentation technology with an AI-driven computational platform to create clean label savory ingredients that give depth, body, and meaty flavors to plant-based foods.
The startup’s enzymatic technology converts up to 80% of the sugars in juice into dietary fibers and non-digestible sugars without impacting the vitamins, minerals and organic acids in the final product.
The Israeli startup expects products containing its animal-free whey protein to launch in the US within the year.
We caught up with Dr. Flatt to discuss the gut barrier, the power of AI, and lessons learned after 30 years of working in biomanufacturing…
Funding in Novel Farming Systems—an AgFunder category spanning indoor farming, insect ag, aquaculture, and algae production—fell off a cliff last year.
A spinoff from VTT in Finland, Enifer is targeting human food, petfood, and aquaculture markets with its mycoprotein, produced from a fungal strain first commercialized in the 1970s.
Who will fund cultivated meat facilities if VC funds are no longer willing to stump up cash for capex projects?
MeliBio is rolling out its first products in partnership with Slovenian food maker Narayan in the UK, Switzerland, and Austria in the first part of a $10m deal to reach 75,000 stores across Europe.
Mush Foods is launching its 50CUT mycelium blends in the US market following a successful launch of its b2b ‘meat-plus’ concept in Israel.
It also teased “a major CPG partner launch” with its whey from fermentation and said it would unveil “new molecules which will bring the impact of precision fermentation to more products and markets.”
Coastal shrimp farming comes with a laundry list of problems. So how do you design an alternate system that can eliminate externalities that threaten coastal systems (extreme weather, disease) and still make a margin?
Sponsored
International Fresh Produce Association launches year 3 of its produce accelerator